azathioprine has been researched along with Liver Failure in 9 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Liver Failure: Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Factors associated with HCV recurrence were evaluated." | 2.79 | Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes. ( Burroughs, AK; Cholongitas, E; Corbani, A; Davidson, B; Davidson, J; Dhillon, AP; Hayes, P; Luong, T; Manousou, P; McCormick, PA; O'Beirne, J; Patch, D; Rodríguez-Perálvarez, M; Rolles, K; Samonakis, D; Thorburn, D; Tsochatzis, E, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sokollik, C | 1 |
| McLin, VA | 1 |
| Vergani, D | 1 |
| Terziroli Beretta-Piccoli, B | 1 |
| Mieli-Vergani, G | 1 |
| Manousou, P | 1 |
| Cholongitas, E | 1 |
| Samonakis, D | 1 |
| Tsochatzis, E | 1 |
| Corbani, A | 1 |
| Dhillon, AP | 1 |
| Davidson, J | 1 |
| Rodríguez-Perálvarez, M | 1 |
| Patch, D | 1 |
| O'Beirne, J | 1 |
| Thorburn, D | 1 |
| Luong, T | 1 |
| Rolles, K | 1 |
| Davidson, B | 1 |
| McCormick, PA | 1 |
| Hayes, P | 1 |
| Burroughs, AK | 1 |
| Soares, JC | 1 |
| Borgonovo, A | 1 |
| Maggi, DC | 1 |
| Pasinato, AP | 1 |
| Ramos, FG | 1 |
| Dantas-Corrêa, EB | 1 |
| Schiavon, LL | 1 |
| Narciso-Schiavon, JL | 1 |
| Kim, BH | 1 |
| Kim, YJ | 1 |
| Jeong, SH | 1 |
| Tak, WY | 1 |
| Ahn, SH | 1 |
| Lee, YJ | 1 |
| Jung, EU | 1 |
| Lee, JI | 1 |
| Yeon, JE | 1 |
| Hwang, JS | 1 |
| Um, SH | 1 |
| Seo, YS | 1 |
| Kim, YS | 1 |
| Song, BC | 1 |
| Kim, JH | 1 |
| Jung, YK | 1 |
| Park, CK | 1 |
| Kim, KA | 1 |
| Min, HJ | 1 |
| Cho, EY | 1 |
| Lee, ES | 1 |
| Kwon, SY | 1 |
| Chae, HB | 1 |
| Kim, DJ | 1 |
| Shin, SR | 1 |
| Lemmens, HP | 1 |
| Langrehr, JM | 1 |
| Blumhardt, G | 1 |
| Lohmann, R | 1 |
| Knoop, M | 1 |
| Verschl, J | 1 |
| Schattenfroh, N | 1 |
| Neuhaus, R | 1 |
| Hopf, U | 1 |
| Bechstein, WO | 1 |
| Bhaskaran, S | 1 |
| Mani, MK | 1 |
| Prakash, KC | 1 |
| Malagó, M | 1 |
| Rogiers, X | 1 |
| Wadström, J | 1 |
| Burdelski, M | 1 |
| Broelsch, CE | 1 |
| Fouad, FM | 1 |
| Mamer, OA | 1 |
| Shahidi, F | 1 |
| Newell, KA | 1 |
| Alonso, EM | 1 |
| Kelly, SM | 1 |
| Rubin, CM | 1 |
| Thistlethwaite, JR | 1 |
| Whitington, PF | 1 |
1 review available for azathioprine and Liver Failure
| Article | Year |
|---|---|
Juvenile autoimmune hepatitis: A comprehensive review.
Topics: Adolescent; Adult; Autoantibodies; Azathioprine; Child; Cholangitis, Sclerosing; Disease Management; | 2018 |
1 trial available for azathioprine and Liver Failure
| Article | Year |
|---|---|
Reduced fibrosis in recurrent HCV with tacrolimus, azathioprine and steroids versus tacrolimus: randomised trial long term outcomes.
Topics: Anti-Inflammatory Agents; Azathioprine; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Hum | 2014 |
7 other studies available for azathioprine and Liver Failure
| Article | Year |
|---|---|
Liver dysfunction and fibrosis as predictors of biochemical response to autoimmune hepatitis treatment.
Topics: Adult; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Bilirubin; Biomarkers; Cross | 2016 |
Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: a nationwide, multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antibodies, Antinuclear; Autoantibodies; A | 2013 |
Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis.
Topics: Antibodies, Monoclonal; Antilymphocyte Serum; Azathioprine; Cyclosporine; Drug Administration Schedu | 1994 |
A study of hepatitis B surface antigen positive patients on haemodialysis and following transplantation.
Topics: Actuarial Analysis; Adolescent; Adult; Aged; Aspartate Aminotransferases; Azathioprine; Child; Femal | 1994 |
Optimal clinical regimens for living related liver transplantation.
Topics: Azathioprine; Bacterial Infections; Child; Child, Preschool; Cyclosporine; Drug Administration Sched | 1994 |
Biogenesis of hepatic acute-phase response to trauma.
Topics: Acute-Phase Proteins; Animals; Azathioprine; Blood Proteins; Carbon Tetrachloride Poisoning; Humans; | 1996 |
Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children.
Topics: Adolescent; Age Factors; Antiviral Agents; Azathioprine; Child; Child, Preschool; Cyclosporine; Foll | 1997 |